Emerson Electric Co saw a price increase of 3.78%, reaching a 20-day high. This surge is attributed to UBS increasing the price target from $131 to $168 and upgrading the stock from Neutral to Buy, signaling enhanced market confidence in its future performance.
The upgrade reflects UBS's positive outlook on Emerson Electric's growth potential, which is expected to drive investor interest and support the stock's upward momentum. This news comes amid broader market strength, with the Nasdaq-100 up 1.06% and the S&P 500 up 0.61%, suggesting a favorable environment for the stock.
As a result of the upgrade and the positive market conditions, Emerson Electric is likely to attract more investor attention, potentially leading to further price appreciation in the near term.
Wall Street analysts forecast EMR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMR is 150.46 USD with a low forecast of 125.00 USD and a high forecast of 170.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
Wall Street analysts forecast EMR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMR is 150.46 USD with a low forecast of 125.00 USD and a high forecast of 170.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
6 Hold
1 Sell
Moderate Buy
Current: 148.420
Low
125.00
Averages
150.46
High
170.00
Current: 148.420
Low
125.00
Averages
150.46
High
170.00
Oppenheimer
Christopher Glynn
Outperform -> Perform
downgrade
2026-01-27
New
Reason
Oppenheimer
Christopher Glynn
Price Target
AI Analysis
2026-01-27
New
downgrade
Outperform -> Perform
Reason
Oppenheimer analyst Christopher Glynn downgraded Emerson to Perform from Outperform without a price target. The firm shuffled ratings in the industrials group. It cites valuation for the downgrade of Emerson. The company's growth prospects are now reflected in the stock's valuation, the analyst tells investors in a research note.
JPMorgan
Stephen Tusa
Neutral
maintain
$150 -> $157
2026-01-16
Reason
JPMorgan
Stephen Tusa
Price Target
$150 -> $157
2026-01-16
maintain
Neutral
Reason
JPMorgan analyst Stephen Tusa raised the firm's price target on Emerson to $157 from $150 and keeps a Neutral rating on the shares. The firm adjusted ratings and targets in the electrical equipment and multi-industry group as part of its Q4 earnings preview. JPMorgan is more positive on "growth related names into and out of the quarter."
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for EMR
Unlock Now
Morgan Stanley
Underweight
maintain
$115 -> $125
2026-01-09
Reason
Morgan Stanley
Price Target
$115 -> $125
2026-01-09
maintain
Underweight
Reason
Morgan Stanley raised the firm's price target on Emerson to $125 from $115 and keeps an Underweight rating on the shares as the analyst is updating estimates ahead of earnings.
TD Cowen
Buy
to
Hold
downgrade
$150
2026-01-09
Reason
TD Cowen
Price Target
$150
2026-01-09
downgrade
Buy
to
Hold
Reason
TD Cowen downgraded Emerson to Hold from Buy with an unchanged price target of $150. The firm cites valuation for the downgrade with the shares close to the price target. Emerson's three-year targets are achievable, but it will take time to determine if there is material upside, the analyst tells investors in a research note. TD says that with Aspen headwinds through the first half of 2026 and uncertainty around a "true momentum turn" in discrete, there "feels like less to do with pure play options available for growth exposures."
About EMR
Emerson Electric Co. is a global technology and software company that provides solutions for customers in a wide range of end markets around the world. The Company operates through seven segments under two business groups, such as Intelligent Devices and Software and Control. Its Intelligent Devices business includes Final Control, Measurement & Analytical, Discrete Automation, and Safety & Productivity. Software and Control business includes Control Systems & Software, Test & Measurement, and AspenTech. Its Final Control segment is a global provider of control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries. Its Measurement & Analytical segment is a supplier of intelligent instrumentation measuring the physical properties of liquids or gases. AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate and maintain their operations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
